Differences between 5‐HT3 receptor antagonists in modulation of visceral hypersensitivity
Open Access
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (2) , 558-562
- https://doi.org/10.1111/j.1476-5381.1995.tb13263.x
Abstract
Noxious colo‐rectal distension was applied in conscious rats by acute balloon inflation and the effects observed as abdominal muscle contraction with the threshold typically between 10–40 mmHg. The effects of 5‐HT3 receptor antagonists on responses to noxious colo‐rectal distension were then studied in both normal rats and those pretreated with 5‐hydroxytryptophan (5‐HTP). Granisetron and ondansetron (10 μg kg−1 and 1 mg kg−1, s.c.) had no effect on visceromotor thresholds to colo‐rectal distension in normal rats. Hypersensitivity of the colo‐rectum was achieved by systemic administration of a low dose of 5‐HTP (10 mg kg−1, s.c.) which lowered the distension pressure required to induce the visceromotor reflex; analysis of variance showed a highly significant treatment effect (F1,11 = 84.26, P−1, s.c. Metoclopramide (10 μg kg−1) also raised the level of distension required to elicit a response. By comparison, tropisetron caused a small, non‐significant increase in visceromotor threshold values and only at high doses (1 mg kg−1), whilst ondansetron and BRL 46470 had no signficant effects at doses up to 10 mg kg−1. The response to granisetron (10 μg kg−1, s.c.) in 5‐HTP‐treated rats was unaltered by pre‐administration of naloxone (5 mg kg−1, s.c). These results suggest that a 5‐HT3‐like receptor modulates 5‐HTP‐ evoked visceral hypersensitivity. However, the rank order of antagonist potency does not correlate with their order of potency against the classically defined 5‐HT3 receptor.Keywords
This publication has 21 references indexed in Scilit:
- Effect of a 5HT3‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT3‐receptor antagonist, in patients with irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Analgesic action of metoclopramide in prosthetic hip surgeryActa Anaesthesiologica Scandinavica, 1993
- MetoclopramideAnesthesia & Analgesia, 1991
- Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple questionPain, 1991
- First Clinical Study of the Selective 5‐HT3 Antagonist, Granisetron (BRL 43694), in the Acute Treatment of Migraine HeadacheHeadache: The Journal of Head and Face Pain, 1991
- Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the ratBrain Research, 1991
- Visceral pain: a review of experimental studiesPain, 1990
- New antiemetic drugsCanadian Journal of Physiology and Pharmacology, 1990
- Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the ratBrain Research, 1988